1. Home
  2. SY vs PEPG Comparison

SY vs PEPG Comparison

Compare SY & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo So-Young International Inc. American Depository Shares

SY

So-Young International Inc. American Depository Shares

HOLD

Current Price

$2.91

Market Cap

289.0M

Sector

Technology

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$5.43

Market Cap

317.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SY
PEPG
Founded
2013
2018
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
289.0M
317.6M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
SY
PEPG
Price
$2.91
$5.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$5.50
$9.50
AVG Volume (30 Days)
786.7K
737.8K
Earning Date
11-17-2025
11-12-2025
Dividend Yield
0.94%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$201,132,009.00
N/A
Revenue This Year
$5.27
N/A
Revenue Next Year
$51.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.67
$0.88
52 Week High
$6.28
$6.72

Technical Indicators

Market Signals
Indicator
SY
PEPG
Relative Strength Index (RSI) 42.74 51.13
Support Level $2.78 $5.08
Resistance Level $3.00 $6.72
Average True Range (ATR) 0.17 0.43
MACD -0.01 -0.08
Stochastic Oscillator 23.64 42.11

Price Performance

Historical Comparison
SY
PEPG

About SY So-Young International Inc. American Depository Shares

So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

Share on Social Networks: